Agreen Biotech Co. Ltd. China, Cellular Biomedicine deal

Cellular completed its acquisition of Chinese cancer supply/service company Agreen in a cash and stock deal. Agreen received about $3.3 million in cash and 822,522 Cellular shares worth $17.2 million ...